CBP在脓毒症应用中的已知新知和探索.pptVIP

* * * In stead of using fixed dose i.e. UF rate 6 l/h, we applied the dose 85 ml/kg/h during the pulse treatment since the body size is the main predictor of patient outcome [12, 18]. Additionally, “continuous” removal of soluble mediators may be the most logical and adequate approach to a complex and long-running process like sepsis we therefore performed PHVHF on the basis of daily treatment and terminated the treatment when improved hemodynamic variables were met. * * 争议的焦点与经验分享 1.不同的声音 24例早期败血症休克 随机进行 48 hrs 等容 CVVH (2L/h) vs 无 CVVH（对照）. 结论 早期 CVVH 并未降低循环细胞因子，过敏毒素水平及MOF. “使用现有肾替代技术的血液滤